In a country where millions are already struggling to afford food, rent and basic healthcare, a breast cancer diagnosis can become a financial crisis of its own. We keep telling women to check their breasts. But what happens when they find something?
Imagine discovering an abnormal change in your breast.
You do what every awareness campaign has told you to do. You book an appointment. You get examined. You undergo the tests. And then the doctor confirms what you have been dreading: breast cancer. There is fear, naturally. There are questions about your body, your future, your family, perhaps your children. You wonder whether you will survive, whether you will lose your hair, whether you will need surgery, whether your life will ever feel normal again.Then comes another question, one that has very little to do with medicine and everything to do with money: How much is this going to cost me?
Not just the first consultation. Not just the scan or biopsy that confirms the diagnosis. The surgery, the chemotherapy, the radiotherapy, the medication, the follow-up appointments. The transport to and from the hospital. The food you may struggle to keep down. The income you lose when you cannot work. The person who has to take time off to accompany you. And dreadfully, what happens when the money runs out before the treatment does?
In Nigeria, breast cancer is not simply a health crisis. For many women, it is a financial one, too. The question is not only whether the disease can be treated, but whether the person who has it can afford to access that treatment long enough to benefit from it. Because apparently, surviving cancer requires a treatment plan. And, increasingly, a financial plan.
Breast Cancer Care In Nigeria
October arrives every year with its familiar shade of pink. Social media timelines fill with reminders to examine our breasts, learn the warning signs and book screenings. Brands release campaigns, organisations host awareness walks, and women are encouraged to take charge of their health. These messages matter. Breast cancer is a serious public health concern in Nigeria, where it is the most commonly diagnosed cancer among women and a leading cause of cancer-related deaths.
According to the International Agency for Research on Cancer’s 2022 estimates for Nigeria, there were approximately 32,278 new breast cancer cases and 16,332 deaths from the disease that year. These figures offer a sobering picture of the burden women face.
But awareness campaigns tend to focus on the moment before diagnosis: know your body, notice a change, seek medical attention. What happens afterwards receives considerably less attention.
A study published in 2022, examining the cost of breast cancer care at a public tertiary hospital in southwestern Nigeria, offers an answer. Among 71 patients receiving treatment with the intention of curing their cancer, the average cost of care was approximately US5,193. While, the average annual amount their households could afford to spend, after accounting for their essential needs, was approximately US 2,867. Read those figures again. The average cost of care was nearly twice the average annual household capacity to pay. Depending on how catastrophic health expenditure was measured, between 79 and 100 per cent of the patients experienced it. Catastrophic health expenditure describes healthcare spending so substantial, relative to a household’s available resources, that meeting it can threaten the family’s financial security. Two-thirds of the patients in the study had no health insurance. While seventy-one patients in one hospital cannot tell us exactly what every Nigerian woman will experience, the financial strain it documents is difficult to dismiss.
For a household already juggling rent, school fees, food and transport, cancer treatment can mean exhausting savings, borrowing from relatives, selling assets or appealing to strangers online. And unlike a one-off emergency expense, cancer treatment may demand money repeatedly over months.
The Cost Of Staying Alive
Cancer treatment is not a single transaction. Depending on the type and stage of the disease, a patient may need surgery, chemotherapy, radiotherapy, hormone therapy, targeted medicines or a combination of treatments. The treatment plan varies from person to person. So does the bill.
Chemotherapy, for instance, is often administered in cycles rather than as a single session. A patient’s financial obligations therefore do not necessarily end after finding enough money for the first treatment. Consider a 2023 fundraising appeal for a patient named Sulia*. Her chemotherapy was reported to cost ₦204,000 per cycle, with five additional cycles still required at the time of the appeal. That meant another ₦1.02 million just for those five cycles, before accounting for any other expenses not covered by that figure. This is an illustration from an individual fundraising appeal, not a current price list or a universal chemotherapy tariff. Treatment costs differ according to the prescribed medicines, dosage, hospital and individual clinical circumstances. But the arithmetic reveals the problem: even when a patient knows what she needs, she may not have the money to obtain it consistently.
For a woman earning a modest monthly salary, ₦204,000 is not pocket change. For a woman who is unemployed, works informally or depends financially on her spouse, it may be an impossible sum to produce every few weeks. And if she has to stop working because of her illness, the money available to fund treatment may shrink precisely when her expenses increase. There is also a distinction between the price of a particular treatment and the total cost of cancer care. A quotation for chemotherapy does not necessarily include diagnostic tests, surgery, other medication, transport, accommodation or the indirect cost of losing income. The more useful thought is therefore not simply, How much does chemotherapy cost? It is: How much money does a woman need, across the entire course of care, to have a realistic chance of completing the treatment her doctor recommends?
Health Insurance In Nigeria
Health insurance is supposed to protect people from the financial consequences of illness. Cancer is precisely the kind of condition for which that protection matters. Yet Nigeria has historically relied heavily on out-of-pocket healthcare payments, leaving patients to pay directly for much of the care they receive. The study of breast cancer patients discussed earlier found that 66 per cent of its participants had no health insurance at all.
Even having insurance does not automatically mean having adequate financial protection. The crucial questions are what the policy covers, whether the relevant hospital and medicines are accessible through it, what limits apply, and what the patient must still pay herself. A policy that covers consultations but leaves a patient struggling to finance expensive medicines, diagnostic procedures or repeated treatment sessions may provide some relief without removing the underlying burden.
Nigeria’s National Health Insurance Authority Act 2022 provides a framework for expanding health insurance coverage. However, expanding enrolment and ensuring that cancer patients receive meaningful protection are two different tasks. For breast cancer patients, meaningful coverage would need to address the costs of diagnosis and medically indicated treatment, with transparent benefit limits, manageable co-payments and a clear process for accessing care. Otherwise, a woman can possess an insurance card and still find herself fundraising for the treatment that could save her life.
When Access Becomes Another Expense
Affordability is usually discussed as though it begins and ends with the price on a hospital invoice. But a service can be technically affordable and still be practically inaccessible. In Nigeria, where specialised cancer services are unevenly distributed, a patient’s postcode can influence the cost of her treatment. A 2025 review of cancer diagnosis and treatment in Nigeria reported only 27 cancer treatment centres serving a population of approximately 218.5 million, based on the data it reviewed. It also highlighted shortages of diagnostic equipment and the concentration of important services in urban areas. These figures describe the situation reported by the review, rather than a live count of every facility currently offering cancer care. Nevertheless, they point to a fundamental challenge: the availability of treatment is not guaranteed simply because a patient has been diagnosed.
Consider a woman living in a rural community who discovers a lump. She may need to travel to a larger town for an ultrasound, return for a biopsy, wait for results and then travel again to consult a specialist. If surgery, chemotherapy and radiotherapy are not available at the same facility, the journey may become even more complicated. Every trip costs money. Every additional appointment can mean another day away from work, another childcare arrangement or another request for assistance. For women who live far from specialised centres, accommodation may become necessary. A relative may need to travel with them. If an appointment is postponed or a machine is unavailable, the patient may incur costs without receiving the treatment she came for.
Sometimes, access isn’t merely about geography. A hospital needs functioning equipment, trained professionals, laboratory and pathology services, reliable supplies and the capacity to provide treatment when patients need it. A machine that exists on paper but is not operational cannot treat anybody. In that sense, the affordability question begins before a patient receives her first bill. It begins with whether the right service exists within a distance she can realistically manage.
The Cost Of A Diagnosis
Before cancer can be treated, it must be diagnosed accurately. A breast lump does not automatically mean cancer. Changes in the breast can have several causes, and a clinical examination alone may not be enough to establish what is happening. Depending on the individual case, a clinician may recommend imaging and a biopsy, followed by laboratory analysis. Each stage can carry a cost.
A review published in 2025, drawing on earlier studies of Nigerian health facilities, reported that 218 facilities offered mammography and that only 33 of 1,336 facilities offering breast ultrasound also offered ultrasound-guided breast biopsy. These are figures reported by the review from its underlying sources, not a verified count of facilities operating today. The distinction matters because identifying an abnormality is not the same as confirming a diagnosis. Patients need access to the services that turn suspicion into reliable medical information. When those services are scarce or concentrated in cities, women may face additional travel, waiting times and expenses. When they are unaffordable, they may postpone investigations or struggle to complete them. And when diagnosis is delayed, treatment can become more complicated.
Late presentation is often discussed in terms of awareness, fear, stigma or misinformation. Those factors deserve attention. But the story is incomplete if we do not also ask whether women can afford the journey from noticing a symptom to getting a definitive answer. It is easy to tell someone not to delay seeking care. It is harder to acknowledge that seeking care may require money she does not have.
The Hidden Costs Of Being Ill
The hospital bill is only part of the financial story. Cancer can affect a patient’s ability to work, earn and care for others. She may need time off for appointments or recovery. She may be unable to maintain the same workload during treatment. A family member who accompanies her may also lose working hours or income. Then there are the everyday expenses: transport fares, meals, childcare and, where necessary, accommodation near a treatment centre.
A household may respond by borrowing money, using savings intended for school fees, selling property or relying on contributions from relatives and friends. Fundraising can be a lifeline, but it is an uncertain one. A patient may need to explain her diagnosis publicly, share intimate details about her health and repeatedly appeal for money while already coping with the physical and emotional effects of illness. There is something particularly dystopian about having to make your medical emergency compelling enough for strangers to fund it.
The financial consequences can extend to the entire household, long after an individual appointment or treatment cycle has ended.
Nigeria’s Cancer Care Fund
A fair investigation must acknowledge the interventions that exist, particularly where they offer real relief. One example is the federal government’s Cancer Health Fund, designed to help eligible indigent patients access cancer treatment. According to a report published by BusinessDay in December 2024, approximately ₦2 billion had been disbursed through the fund, benefiting 1,616 cancer patients. At that time, the programme was reported to be operating in only six tertiary hospitals.
The fund matters because it recognises that patients should not have to bear the entire cost of cancer care alone. But its impact ultimately depends on how many eligible patients can access it, which treatments it supports, how quickly assistance is provided and whether funding is sufficient to meet demand. A patient who does not know the fund exists, cannot access a participating hospital or cannot navigate its application requirements may not benefit from it.
There have also been investments in specialised treatment infrastructure. The NSIA-LUTH Cancer Treatment Centre, inaugurated in 2019, has provided chemotherapy and radiotherapy services alongside other cancer treatments. Nigeria’s National Strategic Cancer Control Plan 2023–2027 also identifies improving access to quality, cost-effective and equitable cancer diagnosis and treatment as a priority.
These efforts deserve recognition. They also invite important questions. How consistently are the policies being implemented? How many patients can benefit? Are facilities adequately staffed and equipped? Is financial assistance reaching people before treatment is interrupted? And what happens to patients who live nowhere near the institutions providing support?
A programme’s existence is an important first step. Its ability to deliver timely, sustained and geographically accessible care is the real test.
What Would Making Breast Cancer Care Affordable Actually Look Like?
First, it would mean treating financial protection as part of cancer care, rather than an afterthought. Health insurance benefits need to provide meaningful coverage for the medically necessary stages of cancer diagnosis and treatment, with clear information about exclusions, limits and patient contributions.
Second, financial assistance programmes need sufficient funding, broader reach and accessible application processes. Patients should be able to find out whether they qualify, what the programme covers and how to apply without navigating an unnecessarily complicated system while ill.
Third, Nigeria needs more functional diagnostic and treatment services distributed across the country. That means investment not only in equipment, but also in trained personnel, maintenance, pathology services, reliable supplies and coordinated referrals. Expanding access would reduce the burden on patients who currently have to travel long distances to obtain specialised care.
Fourth, public hospitals and health authorities should make costs more transparent. Patients need understandable information about likely treatment expenses, what is covered by public programmes or insurance, and where they can seek financial assistance. Estimates should be clearly identified as estimates, not promises of a fixed total bill.
Finally, breast cancer awareness must be connected to services that women can actually use. Education should encourage women to seek medical advice about concerning changes, while campaigns and health facilities provide realistic information about where to go, what diagnostic services are available and how eligible patients can access support.
None of this means that awareness is unimportant. It means awareness should be the beginning of a pathway to care, not the end of the public’s responsibility.
So, Can You Afford To Have Breast Cancer In Nigeria?
Perhaps the more uncomfortable question is why we frame it this way at all.
Nobody chooses breast cancer. Nobody should need to calculate whether a serious illness is financially survivable before seeking medical attention. And yet, when access to treatment depends heavily on household resources, money inevitably becomes part of the equation.
A woman may know the warning signs, attend every awareness event and seek help as soon as she notices a change. She may do everything the public health messaging asks of her. But if she cannot afford the tests required to confirm her diagnosis, cannot travel to a facility offering treatment or cannot pay for the next cycle of medication, awareness alone cannot carry her through.
The answer is not to abandon breast self-awareness, clinical assessment or early diagnosis. It is to stop treating them as sufficient solutions to a problem that extends far beyond individual behaviour. Breast cancer care requires more than telling women to be vigilant. It requires a health system capable of responding when they are. It requires insurance that protects people when they are most vulnerable, public funding that translates into accessible services, facilities that function, and support systems that do not force patients to choose between treatment and the basic needs of their families. A woman who discovers a lump needs more than a reminder to get checked. She needs to know that if the result is cancer, there will be somewhere she can go, treatment she can access and a way to pay for it without sacrificing her family’s future.
